Entity Details

Primary name EAA2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP43004
EntryNameEAA2_HUMAN
FullNameExcitatory amino acid transporter 2
TaxID9606
Evidenceevidence at protein level
Length574
SequenceStatuscomplete
DateCreated1995-11-01
DateModified2021-06-02

Ontological Relatives

GenesSLC1A2

GO terms

Show/Hide Table
GOName
GO:0005313 L-glutamate transmembrane transporter activity
GO:0005314 high-affinity glutamate transmembrane transporter activity
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0006811 ion transport
GO:0006836 neurotransmitter transport
GO:0007268 chemical synaptic transmission
GO:0009986 cell surface
GO:0015501 glutamate:sodium symporter activity
GO:0015813 L-glutamate transmembrane transport
GO:0016020 membrane
GO:0044297 cell body
GO:0045121 membrane raft
GO:0046872 metal ion binding
GO:0070207 protein homotrimerization
GO:0070633 transepithelial transport
GO:0070778 L-aspartate transmembrane transport
GO:0070779 D-aspartate import across plasma membrane
GO:0097449 astrocyte projection
GO:0098712 L-glutamate import across plasma membrane
GO:0098796 membrane protein complex
GO:0099056 integral component of presynaptic membrane
GO:0150104 transport across blood-brain barrier

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001991 Sodium:dicarboxylate symporterFamilyFamily
IPR018107 Sodium:dicarboxylate symporter, conserved siteSiteConserved site
IPR036458 Sodium:dicarboxylate symporter superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
617105 OMIMDevelopmental and epileptic encephalopathy 41 (DEE41)A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE41 inheritance is autosomal dominant. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00142 Glutamic acidDrugbanksmall molecule
DB08868 FingolimodDrugbanksmall molecule

Interactions

6 interactions